Francis Rodier and Nicolas Malaquin make a promising discovery that could reveal new avenues for targeting certain cancers linked to inflammation.
Researchers from the CRCHUM and the Montreal Cancer Institute have published a study on the discovery of a new function performed by proteins responsible for repairing DNA in the Control of Chronic Low-Level Inflammation Associated with Aging “Inflamm-Age”. With aging being the # 1 risk factor for cancer, this finding could reveal new avenues for targeting certain inflammation-related cancers.
The researchers behind this discovery are Nicolas Malaquin, post-doctoral student and first author of the study and Francis Rodier, professor in the Department of Radiology, Radiation Oncology and Nuclear Medicine , who supervised the work of his post-doctoral fellow.
John Stagg : From Lab to Clinic
16 November 2023
Institute Research Member, John Stagg, and his team’s work on pancreatic cancer has led to a clinical study by Trishula […]
New treatment for prostate cancer approved
13 January 2023
An international study led by Dr. Fred Saad has resulted in the approval of a new treatment for metastatic castration-resistant […]